Fundamental Analysis of Pharmaceutical Companies

R. Goel
{"title":"Fundamental Analysis of Pharmaceutical Companies","authors":"R. Goel","doi":"10.2139/ssrn.3481238","DOIUrl":null,"url":null,"abstract":"“Risk comes from not knowing what you’re doing.” These simple yet powerful words by the legendary investor Warren Buffett are the main driving forces of this paper. Investing is by no means a simple process and this paper is a step to help anyone associated with and having knowledge of stock market investments to climb the first ladder towards a brighter investment future. The paper focuses on fundamental analysis of 17 global level competing pharmaceutical companies. The main classification used to categorize the companies was the type of drugs they make i.e., branded, generic and oncogenic. Within this broad classification, the companies have been chosen on the basis of their leading revenue numbers. The paper considers 14 important fundamental ratios that help determine which stock is moving high in the market, in the concerned industry, based on both macroeconomic and microeconomic factors. These ratios can also be used to calculate investment prospects for other sectors.","PeriodicalId":414983,"journal":{"name":"IRPN: Innovation & Finance (Topic)","volume":"35 8 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IRPN: Innovation & Finance (Topic)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2139/ssrn.3481238","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

“Risk comes from not knowing what you’re doing.” These simple yet powerful words by the legendary investor Warren Buffett are the main driving forces of this paper. Investing is by no means a simple process and this paper is a step to help anyone associated with and having knowledge of stock market investments to climb the first ladder towards a brighter investment future. The paper focuses on fundamental analysis of 17 global level competing pharmaceutical companies. The main classification used to categorize the companies was the type of drugs they make i.e., branded, generic and oncogenic. Within this broad classification, the companies have been chosen on the basis of their leading revenue numbers. The paper considers 14 important fundamental ratios that help determine which stock is moving high in the market, in the concerned industry, based on both macroeconomic and microeconomic factors. These ratios can also be used to calculate investment prospects for other sectors.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
制药公司的基本面分析
“风险来自于不知道自己在做什么。”传奇投资家沃伦·巴菲特的这些简单而有力的话语是本文的主要推动力。投资绝不是一个简单的过程,这篇文章是一个步骤,帮助任何与股票市场投资相关并拥有股票市场投资知识的人爬上通往更光明投资未来的第一个阶梯。本文主要对17家具有国际竞争力的制药公司进行基本面分析。用于对公司进行分类的主要分类方法是它们生产的药物类型,即品牌、非专利药和致癌药。在这个广泛的分类中,这些公司是根据其领先的收入数字选出的。本文考虑了基于宏观经济和微观经济因素的14个重要的基本比率,这些比率有助于确定相关行业中哪只股票在市场中处于高位。这些比率也可以用来计算其他行业的投资前景。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Cryptocurrency, Mining Pools' Concentration, and Asset Prices Cryptocurrency, green and fossil fuel investments Property rights in the Crypto age: NFTs and the auctioning of limited edition artwork Does One Size Fit All? Comparing the Determinants of Fintech Market Segments Expansion (Conference Presentation) Bubbles in Ethereum
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1